Rosacea News February 2009

Rosacea News February 2009

1. NRS Awards 2009 Research Grants

The National Rosacea Society have just announced their 2009 research grants. Four studies have been chosen, totally almost $90,000. Quite a buzz for me to see that a study in Australia has made the grade. Dr. Richard Gallo, who has received a lot of press coverage from the research on the role of cathelicidins, and …

2. Tropisetron (Navoban): rosacea patent filed by Galderma

My regular patent trolling has unearthed something potentially interesting. The anti-nausea drug Tropisetron is patented by Galderma as a treatment for inflammatory skin conditions including rosacea. Tropisetron is officially known as a 5-HT3 receptor antagonist or a serotonin antagonist. Serotonin (5-HT) is found widely distributed throughout the gut and the central nervous system ADMINISTRATION OF TROPISETRON FOR TREATING INFLAMMATORY SKIN …

3. seborrheic dermatitis: state of the art, finacea 3 stars

This paper summarises the current state of the art for seborrheic dermatitis – research and treatment options. The author mentions recent research that links seborrheic dermatitis with a spore known as Malassezia Globosa. He makes the point that azelaic …

4. ZincO, Vita-Oil and Oatmeal Cleanser available again soon

Following is an announcement from Rosacea Care. EXCITING NEWS We have just received word that four products that have been important to many rosacea sufferers will be available again later this spring. By arrangement with the originator of these products, the Rosacea Care Company will be manufacturing and distributing ZincO, Tinted ZincO, …

5. L’Oréal strong sales via Galderma and dermatology

L’Oréal has just posted its 2008 Annual Results. The results show that L’Oréal has had a good year, mostly because of the excellent performance of Galderma. It may come as a surprise to many to know that Galderma, the …

6. Sebclair / Atopiclair available in Australia

It looks like Australians can easily get this preparation via mail and pay via paypal.

It appears to be called Atopiclair and is available from It is listed as Atopiclair Cream 40ml and is $49 including postage to anywhere in Australia.

7. Vectical (topical Vitamin D3) approved for Psoriasis

The FDA has recently approvedVectical (topcial vitamin D3 from Galderma) for the treatment of plaque psoriasis. The active ingredient of Vectical is known as calcitrol and is a naturally occurring form of vitamin D3. Calcitrol has been shown safe to use for extended periods up to 52 weeks and also on sensitive skin fold areas. Users of Vectical should avoid exposure to the sun.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s